Indolylmaleimide derivatives
US7786123B2 · kind B2 · utility
0Cited by
0References
3Claims
0Family size
Inventors
Key dates
| Filing date | Jul 7, 2009 |
| Grant date | Aug 31, 2010 |
| Priority date | — |
| Expiry date | Jul 7, 2029 |
Classification
- Technology area (CPC C)Chemistry; Metallurgy
- CPC primaryC07D471/10
- WIPO fieldPharmaceuticals
- WIPO sectorChemistry
Abstract
Indolylmaleimide derivatives comprising either a substituted phenyl, naphthyl, tetrahydronaphthyl, quinazolinyl, quinolyl, isoquinolyl or pyrimidinyl residue have interesting pharmaceutical properties, e.g. in the treatment and/or prevention of T-cell mediated acute or chronic inflammatory diseases or disorders, autoimmune diseases, graft rejection or cancer.
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.